A harried patent attorney hits ‘submit’ on an ex parte reexamination request, mere days before the PTAB drops its hammer.
That’s not drama. It’s Tuesday in Big Tech’s patent wars.
And here’s the USPTO ex parte reexamination scam that’s got everyone—from NPEs to inventors—fuming. The office just announced a pre-order SNQ challenge procedure. Sounds good, right? Wrong. It’s a half-measure that dodges the real rot: petitioners repackaging bombed IPRs as reexams to sidestep estoppel.
“While [the Pre-order Procedure Regarding SNQ] is an important first step and will likely prevent the institution of some—perhaps many—ex parte reexaminations, the real mischief associated with repackaging failed IPRs as reexaminations is not SNQ related.”
Boom. Straight from the experts. This quote nails it—the USPTO’s tweak won’t touch the core abuse.
Look, PTAB denials are up. Discretionary gut-punches via Fintiv and 325(d). Petitioners? They’re pivoting. Hard.
File IPR. Lose (or sense defeat). Then—poof—reexam request, recycling the same prior art. No estoppel if you time it right, before that final written decision lands.
Western Digital’s Masterclass in Timing
Enter Western Digital versus Godo Kaisha IP Bridge. U.S. Patent No. 11,968,909—the ‘909 patent. Storage tech wars, naturally.
WD files IPR September 27, 2024. Full trial. Oral hearing January 23, 2026. Coordinated with two other IPRs on related patents. Multi-front assault.
March 27, 2026: FWD on companion ‘134 patent. Mixed bag—some claims die, others live. Signal received: this panel isn’t your friend.
48 hours later. Days before ‘909 FWD. WD slams in ex parte reexam on claims 5-6, 9-20. Prior art? Kishi and Parkin. Old news—Kishi hit a child app pre-IPR, Parkin was prosecution record.
Why not use ‘em fully in IPR? Estoppel, baby. 35 U.S.C. § 315(e) bars grounds you raised or reasonably could raise post-FWD. File reexam pre-FWD? Dodge city.
It’s not innovation. It’s procedural judo.
Why Does This Reek of Abuse?
Petitioners swear it’s legit—new angles on old art. Sure. And I’m the Easter Bunny.
Timing screams motive. Post-hearing, eve of FWD, after mixed results elsewhere. This isn’t serendipity; it’s strategy.
Patent owners win at PTAB? Provisional. Challenger reroutes to CRU, repackages, restarts. Victory? What victory? It’s whack-a-mole with taxpayer dollars.
And estoppel? Gutted. Congress meant IPRs to end invalidity sideshows. Now it’s a teaser trailer.
My unique take: this echoes the 2000s patent troll heyday—NTP v. RIM, where endless litigation bled BlackBerry dry. Back then, trolls gamed district courts. Today, Big Tech flips the script on NPEs like IP Bridge. Same poison, different vial. History rhymes; reform lags.
USPTO’s SNQ pre-order? Patent owners can now contest substantial new question before institution. Great—for obvious duds. But repackaged IPR art? Same old, new wrapper. SNQ sails through; mischief lives.
The order explicitly delays discretionary factors till after SNQ. Clever. Or gutless.
Short version: half-fix for a full-blown crisis.
Can USPTO Actually Stop the Gaming?
They could. Mandate estoppel across proceedings if art was IPR-known. Or toll FWDs on parallel reexams. Hell, just say no to same-art reruns.
But inertia rules. Director Vidal’s discretionary era clamped IPRs—petitions down 20% last year. Reexams? Filing spike incoming.
Prediction: without teeth, expect a reexam boom. WD’s play? Template for Samsung, Intel, the gang. Patent certainty? Circa 2011 vibes, pre-AIA.
Owners hunker down. Investors flee. Innovation chills—not from trolls, but from endless harassment.
Funny thing: the system meant to clear weak patents now shields them via backlog abuse. Irony much?
We’ve dissected cases like this before at Legal AI Beat—remember those AI patent thickets? Same game, different tech.
Petitioners crow efficiency. Owners cry foul. USPTO? Mumbling procedures while the house burns.
One fix now: expand estoppel to reexams explicitly. Congress? Please. They’re busy with TikTok.
Meanwhile, IP Bridge sweats. WD grinds. Patents twist in the wind.
It’s exhausting. And dumb.
This isn’t protection. It’s legalized harassment.
🧬 Related Insights
- Read more: 450 Companies Fueling the EU’s Vast Migrant Surveillance Web
- Read more: 42% of Law Firms Snag New Clients with AI—ROI’s Hiding in Plain Sight
Frequently Asked Questions
What is ex parte reexamination at USPTO?
Quick, one-sided USPTO review of patent validity on prior art. No patent owner input during exam—hence ‘ex parte.’ Cheaper than IPR, endless appeals possible.
How does IPR estoppel work with reexams?
Post-IPR FWD, can’t raise grounds you knew or shoulda known in district court or IPRs. Reexams? Loophole if filed pre-FWD—argue estoppel doesn’t bite yet.
Will USPTO SNQ changes stop reexam abuse?
Nope. Targets weak SNQ, not repackaged IPR art. Real fix needs estoppel overhaul or filing bans on parallel plays.
